Nocturnal glycemic variability and sleep architecture in children and adolescents with type 1 diabetes: A multi-night home sleep study
Related Experiment Video
Updated: Jun 6, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
C Paulsrud1, S U Thorsen2, A L Moeller1
1Steno Diabetes Center Copenhagen, Herlev, Denmark; Danish Sleep Center for Children and Adolescents, Herlev and Rigshospitalet University Hospitals, Copenhagen, Denmark.
Study Objectives:
Type 1 diabetes (T1D) may disrupt sleep through several mechanisms, including glycemic variability (GV). Few studies have examined nightly GV and its association with sleep architecture. We examined associations between nocturnal GV and sleep architecture in children and adolescents with T1D during the first 4 h of sleep, when stage N3 is most prominent.
Methods:
In this prospective observational study, 62 participants with T1D contributed 233 nights of continuous glucose monitoring and home sleep testing. Linear mixed-effects models examined associations between nocturnal GV, time in hypo- and hyperglycemia, and sleep parameters, adjusting for age, sex, insulin pump type, weekday/weekend, and mean glucose when appropriate.
Results:
Participants were 53.2% female, with a mean age of 12.8 years (SD 2.9). GV was not associated with N3 duration. SD of sensor glucose was associated with lower sleep efficiency (-1.8 percentage points, p = 0.045). Any detected glucose <3.0 mmol/L was associated with lower sleep efficiency (-8.5 percentage points, p = 0.04) and increased wake after sleep onset (+1.8 min, p = 0.01). In age-stratified analyses, severe hyperglycemia (>14 mmol/L) in adolescents was associated with more N2 sleep (+24.1 min, p = 0.001) and less N3 sleep (-14.3 min, p = 0.049). Insulin pump modality did not modify associations.
Conclusion:
Nocturnal GV appeared more strongly related to sleep continuity than to N3 sleep. Findings were broadly consistent in whole-night analyses, with the largest effects observed at extreme glucose values.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

